This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Cryptophthalmos Syndrome
Information about Cryptophthalmos Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Cryptophthalmos Syndrome
Most recent studies have shown that Cryptophthalmos Syndrome shares some biological mechanisms with anophthalmos, atresia, bulla, congenital-abnormality, congenital-absence, congenital-absence-of-kidney, congenital-ocular-coloboma-(disorder), craniofacial-abnormalities, cryptophthalmos, dysplasia, eye-abnormalities, hereditary-diseases, microphthalmos, oligohydramnios, stenosis, syndactyly, tissue-adhesions, urogenital-abnormalities.
Among the many pathways, these few ones have gauged particular interests from scientists studying Cryptophthalmos Syndrome, and have been seen in publications frequently: Basement Membrane Assembly, Cell Adhesion, Cell Death, Cell Migration, Eye Development, Fin Development, Fin Morphogenesis, Kidney Development, Localization, Lung Development, Lung Growth, Membrane Assembly, Membrane Organization, Mesenchymal Cell Migration, Organ Morphogenesis, Ossification, Pathogenesis, Programmed Cell Death, Translation
Quite a number of genes have been found to play important roles in Cryptophthalmos Syndrome, such as CALM1, CALM2, CALM3, CAMKMT, FBLN1, FRAS1, FREM1, FREM2, FREM3, FST, GBGT1, GDNF, GRIP1, HMCN1, KRIT1, LGALS12, NCOA2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.